Dr. Melinda Telli, MD
Claim this profileStanford Cancer Institute Palo Alto
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
17 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER negative
PR negative
2Breast Cancer
HER2 positive
ER negative
PR negative
Affiliated Hospitals
Clinical Trials Melinda Telli, MD is currently running
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Capecitabine
for Triple-Negative Breast Cancer
This trial uses a blood test to find cancer DNA in patients with a tough type of breast cancer. It helps doctors see if the current treatment is working or if a different one is needed.
Recruiting1 award Phase 216 criteria
More about Melinda Telli, MD
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Melinda Telli, MD has experience with
- Pembrolizumab
- Placebo
- Niraparib
- Talazoparib Tosylate
- Capecitabine
- HMBD-002
Breakdown of trials Melinda Telli, MD has run
Breast Cancer
Breast cancer
Minimal Residual Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melinda Telli, MD specialize in?
Melinda Telli, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER negative.
Is Melinda Telli, MD currently recruiting for clinical trials?
Yes, Melinda Telli, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Melinda Telli, MD has studied deeply?
Yes, Melinda Telli, MD has studied treatments such as Pembrolizumab, Placebo, Niraparib.
What is the best way to schedule an appointment with Melinda Telli, MD?
Apply for one of the trials that Melinda Telli, MD is conducting.
What is the office address of Melinda Telli, MD?
The office of Melinda Telli, MD is located at: Stanford Cancer Institute Palo Alto, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford Cancer Institute Palo Alto.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.